课题基金 / 基金详情

The HIV-1 Tat protein is an reverse transcription co-factor.

The HIV-1 Tat protein is an reverse transcription co-factor.
HIV-1 Tat 蛋白是一种逆转录辅助因子。
批准号:
nhmrc : 389826
负责人:
A/Pr David Harrich
金额:
$26.98万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31

项目摘要

项目成果

A/Pr David Harrich的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
HIV-1 is the virus that causes AIDS. In order for HIV-1 to grow, the viral genetic material must be converted into a form that is compatible with a human host. Specifically, the HIV-1 genetic material is made of RNA while the human genome is composed of DNA. An HIV-1 enzyme called reverse transcriptase (RT) is used for this purpose. We have discovered that another HIV-1 protein called Tat is also required for the efficient conversion of HIV-1 RNA into HIV-1 DNA. If HIV-1 lacks Tat, then this transformation process is inefficient and HIV-1 is not able to grow. Recently our group made a breakthrough discovery on how Tat works. Tat can directly bind to RT and stimulate the conversion process. This research is aimed at a detailed analysis of Tat and RT interaction. This information is required in order to understand how this interaction can be blocked in order to stop HIV-1 growth. In the long-term, results produced by this research will be required to discover novel drugs to combat HIV-AIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
  • 批准号:
    nhmrc : GNT1085359
  • 项目类别:
    Project Grants
  • 资助金额:
    $110.11万
  • 财政年份:
    2015
  • 负责人:
    A/Pr David Harrich
  • 依托单位:
eEF1A1 is critical for HIV-1 reverse transcription and replication
The Human Eukaryotic Translation Elongation Factor 1A is a Paramyxovirus Virus Dependency Factor
国内基金
海外基金
可注射磁性Xc-T转运体抑制剂介导铁死亡协同TAT增敏自噬共同崩解“肿瘤抗氧化效应”治疗TNBC
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    梁冰
  • 依托单位:
AIBP通过逆转HIV-1 tat调控的线粒体自噬障碍减少HAND发生的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    严玉娟
  • 依托单位:
TAT-CHIP 融合蛋白减轻脓毒症心功能障碍的作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    吴森泉
  • 依托单位:
AS1411适体/TAT透膜肽引导的核靶向分子探针及肿瘤细胞核中DNA修复酶原位成像研究
  • 批准号:
    82403694
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2024
  • 负责人:
    李伟
  • 依托单位: